Nelson Roberts Investment Advisors LLC Sells 364 Shares of UnitedHealth Group Inc (NYSE:UNH)

Share on StockTwits

Nelson Roberts Investment Advisors LLC trimmed its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,603 shares of the healthcare conglomerate’s stock after selling 364 shares during the period. UnitedHealth Group makes up about 2.3% of Nelson Roberts Investment Advisors LLC’s holdings, making the stock its 10th biggest position. Nelson Roberts Investment Advisors LLC’s holdings in UnitedHealth Group were worth $10,761,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of UNH. Banco Santander S.A. increased its position in UnitedHealth Group by 159.4% in the 4th quarter. Banco Santander S.A. now owns 220,432 shares of the healthcare conglomerate’s stock worth $64,803,000 after purchasing an additional 135,449 shares during the last quarter. Nomura Holdings Inc. boosted its stake in shares of UnitedHealth Group by 474.5% during the 3rd quarter. Nomura Holdings Inc. now owns 561,936 shares of the healthcare conglomerate’s stock worth $122,846,000 after acquiring an additional 464,121 shares in the last quarter. IHT Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 28.9% during the 3rd quarter. IHT Wealth Management LLC now owns 3,671 shares of the healthcare conglomerate’s stock worth $816,000 after acquiring an additional 822 shares in the last quarter. Penserra Capital Management LLC boosted its stake in shares of UnitedHealth Group by 40.4% during the 3rd quarter. Penserra Capital Management LLC now owns 3,915 shares of the healthcare conglomerate’s stock worth $849,000 after acquiring an additional 1,126 shares in the last quarter. Finally, D.A. Davidson & CO. boosted its stake in shares of UnitedHealth Group by 5.6% during the 3rd quarter. D.A. Davidson & CO. now owns 42,996 shares of the healthcare conglomerate’s stock worth $9,344,000 after acquiring an additional 2,264 shares in the last quarter. 76.41% of the stock is currently owned by hedge funds and other institutional investors.

NYSE:UNH traded up $1.04 during mid-day trading on Friday, hitting $254.96. 9,959,326 shares of the company’s stock traded hands, compared to its average volume of 4,473,183. The firm has a 50 day moving average of $290.72 and a two-hundred day moving average of $263.28. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $306.71. The firm has a market capitalization of $249.47 billion, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.25 and a beta of 0.69. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, beating the consensus estimate of $3.77 by $0.13. UnitedHealth Group had a return on equity of 25.55% and a net margin of 5.71%. The firm had revenue of $60.90 billion during the quarter, compared to the consensus estimate of $61.17 billion. During the same quarter in the prior year, the company earned $3.28 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. As a group, equities research analysts expect that UnitedHealth Group Inc will post 16.47 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Monday, March 16th will be paid a dividend of $1.08 per share. The ex-dividend date of this dividend is Friday, March 13th. This represents a $4.32 annualized dividend and a yield of 1.69%. UnitedHealth Group’s payout ratio is 28.59%.

Several analysts have recently issued reports on UNH shares. Deutsche Bank upped their price target on UnitedHealth Group from $297.00 to $362.00 and gave the stock a “hold” rating in a research note on Tuesday, February 18th. Cantor Fitzgerald upped their price target on UnitedHealth Group from $315.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, January 16th. SunTrust Banks upped their price target on UnitedHealth Group from $335.00 to $350.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th. Morgan Stanley reiterated a “buy” rating and set a $312.00 price target (up previously from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Finally, Stephens upped their price target on UnitedHealth Group from $325.00 to $333.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 15th. Five investment analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $318.00.

In related news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 16th. The stock was sold at an average price of $299.45, for a total transaction of $4,491,750.00. Following the completion of the sale, the director now owns 158,598 shares in the company, valued at approximately $47,492,171.10. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $306.04, for a total value of $3,060,400.00. Following the completion of the transaction, the director now directly owns 158,598 shares of the company’s stock, valued at approximately $48,537,331.92. The disclosure for this sale can be found here. 0.87% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: How do investors use RSI to grade stocks?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.